Zobrazeno 1 - 10
of 8 702
pro vyhledávání: '"Neoplasms/*therapy"'
Autor:
Eric M. Genden
Thieme congratulates Dr. Eric M. Genden on being chosen by New York magazine for its prestigious'Best Doctors 2018'list!Head and Neck Cancer: Management and Reconstruction, 2nd Edition by Eric M. Genden masterfully blends two lauded Thieme books, Rec
Autor:
Jorge Paulino, Hélder Mansinho
Publikováno v:
Acta Médica Portuguesa, Vol 36, Iss 10 (2023)
Pancreatic duct adenocarcinoma is currently the sixth-leading cause of cancer death worldwide and the fourth in Europe, with a continuous increase in annual lethality in Portugal during the last two decades. Surgical en-bloc resection of the tumor wi
Externí odkaz:
https://doaj.org/article/7648853487234c8da01bc742562ee696
Autor:
Laurie F. Smaldone, Stehen K. Carter
Publikováno v:
Revista Brasileira de Cancerologia, Vol 32, Iss 1 (2023)
Chemotherapy today is a modality predominantly used to treat metastatic or disseminated malignant neoplastic disease. Depending upon the primary site and stage (extent) of disease, chemotherapy can be geared to be curative or palliative in its intent
Externí odkaz:
https://doaj.org/article/f05de599964b42d19674597bea3b1dc0
Publikováno v:
Liječnički vjesnik, Vol 144, Iss 5-6, Pp 145-149 (2022)
Follow-up of laryngeal carcinoma patients is considered to be the important part of their care. The main purpose of follow-up is to early detect potential disease recurrence and second primary tumous, besides assessment of treatment effectiveness and
Externí odkaz:
https://doaj.org/article/ebf0d7b3786a40e4af25d7ea41c1ba64
Autor:
Anna Maria Buehler, Pierre-Alexandre Dionne, David Chandiwana, Purnima Pathak, Ebuwa Igho-Osagie
Publikováno v:
Revista de Saúde Pública, Vol 56 (2022)
ABSTRACT OBJETIVE To evaluate the effect of ribociclib versus endocrine therapy on productivity losses due to advanced breast cancer. METHODS Productivity data from the MONALEESA-7 trial, obtained from the results of the application of the Work Produ
Externí odkaz:
https://doaj.org/article/3cf4efa63d074111b09bccc8dea8db1f